KalVista Pharmaceuticals reports fiscal second quarter results
KalVista reported the net loss was $3.3 million for 2018 second quarter versus a net loss of $5.0 million for the same 2017 period. Revenue was $5.6 million for the 2018 second quarter versus $1.1 million for the same 2017 period. December 14, 2018